Patents Assigned to Bioglan AB
  • Publication number: 20160081968
    Abstract: The present invention relates to a composition comprising at least one mono-glyceride chosen from glyceryl monocaprylate, glyceryl monolaurate and glyceryl monomyristate, and hydrophilic solvent, having a liquid crystalline lamellar structure at a temperature of above about 37° C., a solid crystalline lamellar structure below about 30° C. and a transformation of said solid and liquid crystalline lamellar structures at from about 30° C. to about 37° C., for use in treatment of cuts and wounds, said composition providing a moisturizing effect of said injury or wound, for reducing scab formation and promote healing in connection with injuries or wounds.
    Type: Application
    Filed: April 23, 2014
    Publication date: March 24, 2016
    Applicant: BIOGLAN AB
    Inventors: Birgitta SVENSSON, Lotta LINSEFORS
  • Patent number: 6537576
    Abstract: The invention relates to a novel biologically active composition which comprises a biologically active agent composition which comprises a biologically active agent to be released therefrom, said biologically active agent being dissolved and/or dispersed in a supersaturated state within a carrier, which carrier comprises a liquid and/or solid non-crystalline ester and/or polyester matrix, and where the precipitation of said biologically active agent is substantially, or completely, inhibited therein. Said supersaturated states is obtainable by subjecting one or more carrier staring substances(s) to such chemical reaction(s) that an ester and/or polyester matrix is provided, the biologically active agent being added after said chemical reaction(s) has (have) been completed.
    Type: Grant
    Filed: January 29, 2001
    Date of Patent: March 25, 2003
    Assignee: Bioglan AB
    Inventors: Åke Lindahl, Håkan Hagslätt, Catharina Benediktsson, Richard Bryland
  • Patent number: 6083518
    Abstract: A biologically active composition comprising a solution of an active agent dissolved in a glass-forming carrier, which carrier comprises a glass-forming substance (A) containing a plasticizer (B), the amount of plasticizer preferably being selected so that the composition has a non-solid consistency. The composition can be prepared by dissolving the active agent in a melted mixture of the glass-forming substance and the plasticizer at a temperature below the decomposition temperature of said active agent. Use of the glass-forming carrier for dissolving a biologically active agent.
    Type: Grant
    Filed: December 17, 1997
    Date of Patent: July 4, 2000
    Assignee: Bioglan AB
    Inventor: .ANG.ke Lindahl
  • Patent number: 5550145
    Abstract: An antimicrobial composition comprising an antimicrobially effective amount of a combination of: A) a monoglyceride of lauric acid, a monoglyceride of monomyristic acid or a mixture of these monoglycerides, and B) at least one chemical substance selected from the following groups: i) local anesthetics of the amide type; ii) carbamide, iii) antibacterial substances in the form of steroid antibiotics, imidazole derivatives or nitroimidazole derivatives, and iv) diols with 3-6 carbon atoms, and C) optionally, a conventional physiologically acceptable carrier and/or physiologically acceptable additives. A process for the preparation of this composition by heating (A) to the transition temperature of the lipid, adding (B), and optionally (C), and cooling the mixture to form a solid lipid crystal composition. Use of the composition for the preparation of a dermatological preparation for combatting bacteria and fungi or as a preservative additive in a cosmetic product, a food product, or a medical product.
    Type: Grant
    Filed: September 27, 1994
    Date of Patent: August 27, 1996
    Assignee: Bioglan AB
    Inventors: Karin Olund, Lena-Karin L utz, Rickard Bryland, .ANG.ke Lindahl